FDA Approved: BANZEL — Original Application (Eisai Inc.)

View source ↗

Summary

The FDA approved the original application for BANZEL (rufinamide) from Eisai Inc. for the treatment of seizures associated with Lennox-Gastaut syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Banzel (rufinamide)

Snippet

ORIG AP for BANZEL (RUFINAMIDE)